Irreversible Ototoxic Effect of Erythromycin
- 1 January 1986
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Audiology
- Vol. 15 (1) , 41-42
- https://doi.org/10.3109/01050398609045952
Abstract
Between 30 and 40 cases of reversible ototoxic side effects of erythromycin therapy have been reported previously but to our knowledge none with irreversible adverse reactions. A case of persistent tinnitus after intravenous erythromycin therapy is reported in the following.This publication has 9 references indexed in Scilit:
- Ototoxic Effect of Erythromycin TherapyJAMA Otolaryngology–Head & Neck Surgery, 1984
- Erythromycin ototoxicityThe Medical Journal of Australia, 1982
- Ototoxicity of erythromycin gluceptateAmerican Journal of Obstetrics and Gynecology, 1981
- Probable Erythromycin OtotoxicityDrug Intelligence & Clinical Pharmacy, 1980
- Legionnaires' Disease: Unusual Clinical and Laboratory FeaturesAnnals of Internal Medicine, 1980
- Ototoxicity of erythromycin lactobionateActa Clinica Belgica, 1979
- OTOTOXICITY OF ERYTHROMYCINThe Lancet, 1978
- Transient Perceptive Deafness due to Erythromycin LactobionatePublished by American Medical Association (AMA) ,1973